Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen

BMJ Case Rep. 2022 May 10;15(5):e247159. doi: 10.1136/bcr-2021-247159.

Abstract

We report a case of Susac syndrome after SARS-CoV-2 infection and subsequent vaccination that presented with meningitis and retinal microembolisation in the form of paracentral acute middle maculopathy (PAMM). After presenting with headache, fever and myalgia followed by scotomata, a woman in her 50s was hospitalised for meningitis; she had had mild COVID-19 infection 2 months prior to admission, having received the first vaccine dose 1 month prior to the neurological manifestation. Eye fundus examination and optical coherence tomography were suggestive of PAMM. D-dimer levels and erythrocyte sedimentation rate were elevated. Before infectious investigation results were available, she was started on empirical antibiotic and antiviral treatment. Having ruled out infectious causes, she was started on high-dose prednisolone. After 1 month, there was partial resolution of retinal lesions. This case highlights that exposure to SARS-CoV-2 antigen may be related to this rare syndrome; treatment with steroids may improve central and retinal impairment.

Keywords: COVID-19; Ear, nose and throat/otolaryngology; Neurology; Retina; Vaccination/immunisation.

Publication types

  • Case Reports

MeSH terms

  • COVID-19*
  • Female
  • Fluorescein Angiography / methods
  • Humans
  • Macular Degeneration* / complications
  • Retinal Diseases* / diagnosis
  • Retinal Diseases* / drug therapy
  • Retinal Diseases* / etiology
  • Retinal Vessels / pathology
  • SARS-CoV-2
  • Susac Syndrome*
  • Tomography, Optical Coherence / methods